The DOI matches its Crossref record.
Combined Dialectical Behavior Therapy and Fluoxetine in the Treatment of Borderline Personality Disorder
Abstract
BACKGROUND: This study examines the therapeutic effect of fluoxetine, a selective serotonin reuptake inhibitor, added to dialectical behavior therapy (DBT), an empirically supported psychosocial therapy, for the treatment of borderline personality disorder. METHOD: This is a 12-week, randomized, double-blind, placebo-controlled study of patients with borderline personality disorder (identified using the Structured Clinical Interview for DSM-IV Axis II Disorders). All subjects received individual and group DBT. Of the 20 subjects that completed treatment, 9 were randomly assigned to receive up to 40 mg/day of fluoxetine and 11 were randomly assigned to the placebo condition. Subjects were evaluated at baseline and at week 10 or 11 on self-report measures of depression, anxiety, anger expression, dissociation, and global functioning. The study was conducted between January 1998 and February 2000. RESULTS: Time-by-group interaction effects revealed no significant group differences in scores from pre-treatment to posttreatment on any measure. However, within the DBT/placebo group, there were significant pretreatment/posttreatment differences in the direction of improvement on all measures. No significant pre-treatment/posttreatment differences were found within the DBT/fluoxetine condition. CONCLUSION: The data suggest that adding fluoxetine to an efficacious psychosocial treatment does not provide any additional benefits. Further studies with larger sample sizes are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the pharmacotherapy review (Stoffers 2010) included three trials testing psychotherapy plus drug against psychotherapy plus placebo (Simpson 2004;Soler 2005;Linehan 2008).”
From Psychological therapies for people with borderline personality disorder. (2012) · cites this paper as Simpson 2004
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–156 of 156
Evidence-Based Pharmacotherapy for Personality Disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.225 · Cited by 2
Marin, L. K., Kapil-Pair, K. N., Harris, R. E., & Goodman, M. S. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0124-y · Cited by 2
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22484-3.00021-9 · Cited by 2
Pharmacotherapy of Personality Disorders
Baumann, P., & Herpertz, S. C. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_252-1 · Cited by 2
Schmeck, K., & Romanos, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_20 · Cited by 2
Black, D. W., Paris, J., & Schulz, C. S. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch7 · Cited by 2
Mindfulness-Based Therapies for Psychological Health Conditions: A Meta-Analysis
McCarney, R. (2010) · University of Hertfordshire Research Archive (University of Hertfordshire) · Cited by 2
Pharmacology of Personality Disorders
Triebwasser, J., & Siever, L. J. (2006) · Cited by 2
Herpertz, S. C. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_50 · Cited by 2
Gérolymos, C., Garosi, A., Boyer, L., Yon, D. K., Rahmati, M., Gavaudan, M., & Fond, G. B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03451-4 · Cited by 1
Li, Y., & Mao, W. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117055 · Cited by 1
Overview of the treatment for borderline personality
Veerasamy, K., & Guruvaiah, L. (2013) · Sri Lanka Journal of Psychiatry · doi:10.4038/sljpsyc.v4i2.5698 · Cited by 1
Herpertz, S. C., & Bronisch, T. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_79-1 · Cited by 1
Silk, K. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5_11 · Cited by 1
Schmeck, K., & Romanos, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_21 · Cited by 1
Advances in Treatment for Personality Disorders
Biskin, R. S., & Paris, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_19 · Cited by 1
Pharmacotherapy of Personality Disorders
Baumann, P., & Herpertz, S. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_252 · Cited by 2
Selective serotonin reuptake inhibitors and the utility of the borderline‐bipolar distinction
Magalhães, P. V. D. S. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00477.x · Cited by 1
Treatment of Comorbid Anxiety Disorders and Personality Disorders
Arntz, A. R. (2014) · doi:10.1002/9781118775349.ch54 · Cited by 1
THE ADDICTION SEVERITY INDEX MULTIMEDIA VERSION
Budman, S. H., Butler, S. F., & Villapiano, A. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088520-6.50008-1 · Cited by 1
Borderline-Persönlichkeitsstörungen (ICD-10 F6)
Bohus, M., & Lieb, K. (2007) · Elsevier eBooks · doi:10.1016/b978-343724131-4.50021-4 · Cited by 1
Ingenhoven, T., & Rinne, T. (2007) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6404-6_18 · Cited by 1
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2009) · Elsevier eBooks · doi:10.1016/b978-343722481-2.50025-8
Empfehlung zur pharmakologischen Behandlung von Borderline-Persönlichkeitsstörungen
Lieb, K., & Stoffers-Winterling, J. M. (2014) · Ärztliche Psychotherapie und Psychosomatische Medizin
14 Werkzaamheid en werkzame factoren van psychotherapie
Verheul, R. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6821-1_14
Persönlichkeitsstörungen (F60, F61)
Romanos, M., & Wewetzer, C. (2009) · Springer eBooks · doi:10.1007/978-3-211-79275-9_25
Guideline Development Group Membership
Tyrer, P. J., Kendall, T., BATEMAN, A. W., Psychiatrist, C., Bayliss, L., & Bouras, N. (2005)
Overview of the treatment for borderline personality disorder
Veerasamy, K., & Guruvaiah, L. (2013)
Caracterización del Trastorno Límite de la Personalidad y efectos del entrenamiento en mindfulness
Feliu‐Soler, A. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Werkzaamheid en werkzame factoren van psychotherapie
Verheul, R. (2007) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6404-6_13
Pharmacotherapy of Personality Disorders
Öyekçin, D. G., & Yıldız, D. (2012) · Journal of Mood Disorders · doi:10.5455/jmood.20120328094704
Pharmacologic interventions for antagonism and related disorders
Johnson, A. C. L., Wichser, L. M. H., & Nelson, K. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814627-9.00026-8
Ruminjo, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/sxw0-fj35
Psychopharmacologie du trouble de la personnalité borderline
Perroud, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76266-6.00010-0
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-22483-6.10021-x
González, C., de Toro, M. B., Lopez-Munoz, F. J., & Martín, J. D. D. M. (2011) · Edupsykhé Revista de Psicología y Educación · doi:10.57087/edupsykhe.v10i2.3852
Transtorno de personalidade borderline
da Silva, D. A. R. (2018) · doi:10.47749/t/unicamp.2018.1063978
Herpertz, S. C., Habermeyer, V., & Bronisch, T. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_66
Current awareness in human psychopharmacology
(2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.632
(2013) · CRC Press eBooks · doi:10.1201/b15462-35
Romanos, M., Wewetzer, C., & Schmeck, K. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_22
Herpertz, S. C. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_85
Pharmakotherapeutische Ansätze
Priebe, K., Schmahl, C. G., & Stiglmayr, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-35066-5_9
Arntz, A. R., & van Genderen, H. (2020) · Wiley eBooks · doi:10.1002/9781119101161.refs
Werkzaamheid en werkzame factoren van psychotherapie
Verheul, R. (2017) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0931-3_15
Chapter 56. Treatment of Personality Disorders
Hollander, E., Vats, T., & Desilva, N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as56
Pharmacological and nutraceutical treatments for borderline personality disorder
Gérolymos, C., Boyer, L., Masson, M., & Fond, G. B. (2024) · L Encéphale · doi:10.1016/j.encep.2024.04.001
Grundlagen der Diagnostik und Therapie
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-22487-4.16001-0
Simon, L., Warlick, H., Jafarmadar, A., Joubran, E., Koleng, M., Owens-Charles, C. R., Ramanathan, P., Rodriguez, J. R., Singer, S., & Gallicchio, V. S. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1707007
Sublette, M. E., Byrnes, A., Ogden, R. T., Zanderigo, F., Burke, A. K., Oquendo, M. A., Stanley, B., Mann, J. J., & Miller, J. M. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.05.028
Miño-Reyes, V., Larenas-Matta, P., Quijada-Leyton, M. J., & Nvo-Fernández, M. (2026) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2026.100763 · Cited by 1
Metadata
- Authors
- Simpson, E. B., Yen, S., Costello, E., Rosen, K., Begin, A., Pistorello, J., & Pearlstein, T.
- Affiliations
- Harvard University (US)
- Brown University (US)
- University of Nevada, Reno (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-03-15
- Volume
- 65
- Issue
- 3
- Pages
- 379-385
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2025624676
- Cited by
- 156
- References
- 0
- Citations by year
- 2026: 5 · 2024: 7 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 9 · 2016: 3 · 2015: 3 · 2014: 11 · 2013: 12 · 2012: 10
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- borderline personality disorder, dialectical behavior therapy, fluoxetine, selective serotonin reuptake inhibitors, psychosocial interventions, depression, anxiety, anger expression, dissociation, global functioning
- MeSH terms
- Adult, Behavior Therapy, Borderline Personality Disorder, Combined Modality Therapy, Double-Blind Method, Female, Fluoxetine, Humans, Surveys and Questionnaires, Selective Serotonin Reuptake Inhibitors, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
